The Reducing Adverse Outcomes in Dialysis by Adjusting the pRescription for Dialysate Potassium Trial

This will be a randomized controlled pilot trial comparing usual care to a precision approach to dialysis potassium prescribing. The precision approach will incorporate point of care testing of blood potassium concentration prior to each dialysis session and adjustment of the dialysate K prescription with a blood-dialysate K gradient minimization strategy (PKRxHD).

NCT Number	NCT07051447
Lead Sponsor	NYU Langone Health Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions	End Stage Kidney Disease
Enrollment	120 participants
Start Date	2025-08-01
Primary Completion	2029-02-01 (estimated)
Study Completion	2029-08-01 (estimated)
Updated on ClinicalTrials.gov	2025-07-04